Effect of Sensorimotor Training on Upper Extremity in Parkinson's Patients

February 20, 2024 updated by: Ozlem Menevse, Hacettepe University

Investigation of the Effect of Sensorimotor Training on Upper Extremity Functions, Activity and Participation in Parkinson's Patients

There are many factors affecting the upper extremity such as tremor, bradykinesia, rigidity, and postural instability in Parkinson's patients. According to the International Classification of Functioning, Disability and Health (ICF) model, there are restrictions on people's activities and participation in life due to structural and functional disorders affecting the upper extremity in PD.

In PD, integrating and using proprioceptive feedback, sensorimotor integration and peripheral sensory functions are reported to be impaired. Numerous studies show that the main source of motor problems in PD is dysfunction of sensorimotor integration. Since the cervical region contains a dense concentration of proprioceptive organs such as muscle spindles, it plays an important role in providing afferent proprioceptive information for postural control. Therefore, sensorimotor training targeting the cervical region gains importance. In this study, we aim to reduce PD-specific upper extremity disorders and related activity and participation limitations by increasing motor control in the cervical region with sensorimotor training. Patients with Parkinson's disease will be included in the study and randomly divided into 2 groups. While the general physiotherapy program will be applied to the control group, sensorimotor training will be given in addition to the exercise group.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

27

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kayseri, Turkey
        • Nuh Naci Yazgan University, Department of Physiotherapy and Rehabilitation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Having idiopathic Parkinson's disease over the age of 40
  • Meets the diagnostic criteria of the United Kingdom Parkinson's Disease Society Brain Bank
  • Hoehn-Yahr Staging <3
  • Mini mental test score of 24 and above
  • In the "on" period
  • Receiving oral therapy only

Exclusion Criteria:

  • Patients receiving device-assisted therapy
  • Patients receiving apomorphine therapy
  • Patients with mini mental test scores below 24
  • Patients who use drugs (antidepressants, etc.) that will affect cognitive functions
  • Patients with hearing and speech problems
  • Patients with orthopedic, neurological and vestibular problems other than Parkinson's that may prevent them from completing the tests and treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control Group
Patients in this group will receive standard physiotherapy program used for PD will be applied, 3 times a week for 8 weeks.
Treatment protocol; It will be applied to improve posture, strengthen muscles, eliminate shortness, increase flexibility, balance/coordination, sit up/stand up and in-bed mobilization, and improve gait. Before taking the treatment, a general evaluation will be made and as a result of this evaluation, muscle shortness, loss of strength, postural disorders and the activities and positions they have the most difficulty in daily life will be determined. Treatment programs will be shaped according to the problems determined in line with the evaluations made.
Experimental: Exercises Group
In addition to standard physiotherapy programme, patients in this group will also receive sensorimotor training.
In addition to the standard physiotherapy program, sensorimotor training including the cervical region will be given to the this group. Deep cervical flexor and extensor muscles, which provide stability in the cervical region, will be trained. A Pressure Biofeedback Device will be used to train the deep cervical flexors. Both positional and kinesthetic sensory training will be provided by maintaining the stability of the cervical region by means of the laser kit that provides visual feedback.Additionally, oculomotor exercises will be given.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Posture Analysis
Time Frame: Change from baseline at 8 week
New York Posture Rating Chart
Change from baseline at 8 week
Tremor
Time Frame: Change from baseline at 8 week
Fahn; Tolosa, Marin Clinical Tremor Rating Scale will be used to evaluate tremor. Each item was scored between 0-4. A lower score is an indicator of better status.
Change from baseline at 8 week
Unified Parkinson's Disease Rating Scale
Time Frame: Change from baseline at 8 week
Unified Parkinson's Disease Rating Scale is a scale that evaluates disability and disorders related to Parkinson's and consists of 4 main subtitles and 42 questions in total . Each item was scored between 0-4 . A lower score is an indicator of better status.
Change from baseline at 8 week
Proprioception
Time Frame: Change from baseline at 8 week
For proprioception, joint position error in the cervical region and upper extremity will be evaluated with the laser kit.
Change from baseline at 8 week
Tactile acuity
Time Frame: Change from baseline at 8 week
For upper extremity tactile acuity, moving 2-point discrimination test (MTPD) will be performed using an esthesiometer.
Change from baseline at 8 week
Touch threshold
Time Frame: Change from baseline at 8 week
Semmes Weinstein Monofilament Test will be used to evaluate upper extremity touch threshold.
Change from baseline at 8 week
Pain threshold
Time Frame: Change from baseline at 8 week
Algometer will be used to evaluate upper extremity pain threshold.
Change from baseline at 8 week
Pain intensity
Time Frame: Change from baseline at 8 week
Visual pain scale (VAS) will be used to evaluate upper extremity pain.In the evaluation, pain averages ranging from 0 to 10 cm are given. "0" indicates that there is no pain, while as the score increases, the severity of pain increases.
Change from baseline at 8 week
Hand Grip Strength
Time Frame: Change from baseline at 8 week
Hand Dynamometer will be used to measure hand grip strength.
Change from baseline at 8 week
Pinch Grip Strength
Time Frame: Change from baseline at 8 week
Pinch meter will be used to measure pinch grip strength.
Change from baseline at 8 week
Fatigue
Time Frame: Change from baseline at 8 week
Parkinson's Fatigue Scale will be used to evaluate fatigue. It is consists of 16 items related to presence of fatigue. All items are scored by patients using a five-point Likert-type scale including response options ranging from '(1) strongly disagree' to '(5) strongly agree'. A higher score indicates a higher level of fatigue.
Change from baseline at 8 week
Hand functions
Time Frame: Change from baseline at 8 week
Purdue Pegboard Test (PPT)
Change from baseline at 8 week
Dual Task Performance
Time Frame: Change from baseline at 8 week
During the Purdue Pegboard Test, the second task will be added and the completion time will be recorded.
Change from baseline at 8 week
Disabilities of the Arm, Shoulder and Hand Questionnaire
Time Frame: Change from baseline at 8 week
It will be used to determine the problems experienced in the use of the upper extremity. It consists of 3 sections. All questions are answered according to a 5-point Likert system. A score between 0-100 is obtained from each section. The higher the score, the higher the disability.
Change from baseline at 8 week
Quality of life evaluation
Time Frame: Change from baseline at 8 week
Parkinson's Disease Questionnaire (PDQ-39) will be used to evaluate quality of life. It contains 39 items in total. A score between 0 and 4 is given for each question. A high overall score indicates worsening quality of life.
Change from baseline at 8 week
Evaluation of Environmental Factors
Time Frame: Change from baseline at 8 week
Questions structured by the researchers will be used on the issues of support and attitudes under the environmental factors heading of the ICF model. Questions are scored between 0 and 10. A high score indicates high satisfaction.
Change from baseline at 8 week
Motor speed
Time Frame: Change from baseline at 8 week
Motor speed will be evaluated using the Finger tapping test.
Change from baseline at 8 week
Endurance of Cervical Muscles
Time Frame: Change from baseline at 8 week
Craniocervical Flexion (CSF) test, Evaluation of cervical flexor-extensor muscles
Change from baseline at 8 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 8, 2021

Primary Completion (Actual)

November 20, 2023

Study Completion (Actual)

November 20, 2023

Study Registration Dates

First Submitted

January 7, 2022

First Submitted That Met QC Criteria

February 6, 2022

First Posted (Actual)

February 15, 2022

Study Record Updates

Last Update Posted (Estimated)

February 22, 2024

Last Update Submitted That Met QC Criteria

February 20, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson Disease

Clinical Trials on Control Group

Subscribe